Andres Felipe Valdivia (Andres Valdivia)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Induced Apoptosis

Cancer Stem Cells

Cell Cycle Arrest

Top Venues

Molecular cancer therapeutics

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum through Nicotinamide N-methyltransferase. Molecular cancer therapeutics (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Yaqi Zhang, Yinu Wang, Andres Felipe Valdivia, Hao Huang, Daniela E Matei
DOT1L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling. Molecular cancer research : MCR (2022)